China NMPA Product Recall - Human Immunodeficiency Virus Type 1 Nucleic Acid Assay Kit

Abbott Trading (Shanghai) Co., Ltd. initiated a voluntary Class II recall of its Human Immunodeficiency Virus Type 1 Nucleic Acid Assay Kit (Imported Medical Device Registration Certificate No. 20163401719). The company reported that affected products may generate unexpected error codes and elevated error rates, directly impacting the reliability and accuracy of HIV Type 1 nucleic acid detection. This critical issue poses a potential risk to patient diagnosis and subsequent medical management. The recall, publicly announced on September 7, 2017, by Abbott Trading (Shanghai) Co., Ltd., reflects the company's commitment to product safety and adherence to medical device regulations under the applicable regulatory framework. The required action involves the comprehensive recall of all affected models, specifications, and batches of the Human Immunodeficiency Virus Type 1 Nucleic Acid Assay Kit to prevent further use of potentially faulty diagnostic tools, thereby safeguarding public health standards and ensuring the integrity of medical testing. Specific inspection dates were not detailed in the provided document.